Skip to main content
. 2020 Jan 24;11:10. doi: 10.3389/fendo.2020.00010

Figure 1.

Figure 1

(A) Immunostaining of chromogranin highlighted the enlarged and irregular islets (10x); (B) ductuloinsular complexes haematoxylin-eosin staining (40x); (C) islets with diffuse positivity for insulin (10x); and (D) neuroendocrine tumor immunoreactive for insulin (10x).